NOTCH1 and breast cancer: Thus, co-treatment of CNC and Doxo may have a substantial improvement in clinical outcome exhibiting an effective strategy for TNBC treatment, as well as, modulation of Notch1 pathway could give enhanced effect and, therefore, might reduce Doxo-induced side effects and resistance in breast cancer treatment35.